Shu Tian, Qin Zhao, Xin Jiang, Xiaoshen Wang. "Penpulimab (AK105) combined with cetuximab as first-line treatment in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II clinical trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6029